Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From E.ON
Amid the highly successful launch of COVID-19 vaccines using the technology by Pfizer/BioNTech and Moderna, South Korean bioventure OliX Pharmaceuticals is diversifying into the mRNA field by establishing a new subsidiary that focuses on R&D into new vaccines and therapeutics using the platform.
South Korea's Ministry of Health and Welfare will cut the prices of five products from Daewoong Pharmaceutical by 20% from May following a Seoul court's ruling last year that found the pharma firm guilty of providing illegal rebates in return for prescriptions.
The acquisition of Biotech International is intended to provide Wright with a complementary extremity product portfolio and to significantly expand Wright’s direct sales channel in France and international distribution network for foot and ankle products.
With hip and knee joint markets still registering slow to modest growth, orthopedic companies looking to add bulk to their bottom line through mergers and acquisitions have pursued two distinct directions – the extremities and emerging markets.